Teva Launches Generic Pravachol Following Appeals Court Dismissal Of Apotex
This article was originally published in The Pink Sheet Daily
Executive Summary
Watson concurrently launched an authorized generic of Bristol's pravastatin, but Ranbaxy's 80 mg ANDA remains on hold.
You may also be interested in...
Pravachol Generic Takes Its Toll On Bristol’s Pharma Sales
Global Sales of Bristol-Myers Squibb's blockbuster cholesterol drug Pravachol tumbled 48.3% to $323 mil. in the second quarter following the launch of generic pravastatin early in the quarter
Pravachol Generic Takes Its Toll On Bristol’s Pharma Sales
Global Sales of Bristol-Myers Squibb's blockbuster cholesterol drug Pravachol tumbled 48.3% to $323 mil. in the second quarter following the launch of generic pravastatin early in the quarter
Caremark Reaps Pricing Benefit From AdvancePCS Acquisition
The PBM is looking for additional mergers and acquisitions outside pharmacy benefit management.